CD19 chimeric antigen receptor T-cell therapy as a bridge therapy for allogeneic hematopoietic stem cell transplantation in patients with relapsed Philadelphia chromosome-positive acute lymphoblastic leukemia.
Zhenzhen YaoBin GuYanming ZhangJiaqian QiJia ChenYang XuFeng ChenXiao MaMiao MiaoSheng-Li XueHuiying QiuXiao-Wen TangYue HanSuning ChenAining SunLei YuDe-Pei WuYing WangPublished in: Bone marrow transplantation (2022)